The IPO Mirror Test: Why Billions Are Betting on Robotic Arms Over Fast Fashion
(SeaPRwire) – By: Oliver Hawthorne
The Shanghai STAR Market and Hong Kong exchange are running parallel dramas this August. On one side, Unitree Robotics — a company valued at $9 billion that has spent years refining humanoid robots — is launching an IPO that retail investors are devouring at 8,000 times oversubscription. On the other, Shein, a $25-to-$30 billion fast-fashion titan, is stumbling toward its long-delayed listing with a valuation that has cratered from $64 billion in 2024. The math is simple. The market is telling us something loud and clear.
Unitree’s numbers are not speculative. It raised 6.1 billion yuan — roughly $904 million — at that $9 billion valuation. Revenue hit 1.7 billion yuan last year, a fourfold jump from 2024. Net income came in at 600 million yuan, or $89 million. Almost 45% of revenue originates from overseas. Over 70% of its humanoid robots go to academic and research institutions, with some Chinese state-owned enterprises and major manufacturers also deploying them. The company is profitable at a time when UBTech posted a $104 million net loss and Boston Dynamics and Figure AI remain deeply in the red. Smart Analytics Global reports that Chinese firms accounted for 97% of all humanoid robot shipments in the first half of the year. Agibot — not Unitree — now holds the market leadership title. Unitree is preparing for a Shanghai debut. Agibot is targeting a Hong Kong listing later this year.
Shein’s situation reads like a case study in how timing and geopolitics compound business risk. The company pulled in $41.2 billion in revenue last year against $38.8 billion in 2024. Profit landed around $2 billion. Europe now represents 35.4% of revenue, surpassing the U.S. at 24.1%. But the de minimis exemption — the low-value customs loophole that powered Shein’s cross-border model — was eliminated by the United States last year and by Europe in July. The company’s own prospectus warns that EU trends could match or exceed the U.S. impact. Its valuation path from $100 billion in 2022, down to $64 billion in 2024, and now priced between $25 and $30 billion tells a story of capital losing faith. Shein tried a New York listing and hit forced-labor and data-safety objections. It moved its headquarters to Singapore in a move journalists called “Singapore-washing.” It considered London. Chinese regulators withheld approval. Hong Kong was left as the only door.
The broader market context reinforces the contrast. ChangXin Memory Technologies raised $8.6 billion in its Shanghai STAR Market IPO last month. Shares surged up to 530% on debut. The chipmaker — the world’s No. 4 DRAM producer — is now valued ahead of Tencent. DeepSeek, Moonshot AI, and Yangtze Memory Technologies are all circling either Shanghai or Hong Kong listings. Capital is flowing toward AI infrastructure and hardware. It is pulling away from e-commerce platforms and internet business models.
What happens next is the real question. Unitree’s profitability and its dominance in the lower-cost humanoid and quadruped segments give it a runway that UBTech and its American peers have yet to find. The FCC’s late-July import ban on foreign-made humanoid and quadruped robots is a direct response to supply chain and national-security concerns. That restriction isolates the U.S. market from Chinese robotics firms but simultaneously validates the strategic importance of the sector. Washington is treating these robots as critical infrastructure. That framing tends to accelerate domestic investment and international competition in equal measure.
Shein’s path is harder to reverse. The loss of de minimis changes its unit economics fundamentally. European and American regulators are signaling that the low-cost parcel model is no longer welcome without structural concessions. A Hong Kong listing provides liquidity but does not solve the margin compression or the geopolitical overhang. The company may need to localize more aggressively, build regional supply chains, and accept thinner margins if it wants to sustain growth in a world where cross-border duty-free trade is dying.
The underlying thesis is straightforward. Capital markets reward scarcity and optionality. Humanoid robotics in China is scarce in terms of profitability and optionality in terms of industrial application. Fast fashion is abundant, regulated, and margin-constrained. The IPO pipeline this month makes that distinction visible in real time.
Author bio: Oliver Hawthorne, Principal Correspondent for an international technology review, covering global IPO markets, semiconductor supply chains, and the intersection of robotics policy and commercialization.